Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease
Aim: Herein, we report safety outcomes for varenicline solution nasal spray (VNS) within the context of clinical trial discontinuation, contrasting those with discontinuation outcomes from topical cyclosporine and lifitegrast clinical trials. Materials & methods: 1061 subjects were randomized ac...
Saved in:
Main Authors: | Alan G Kabat (Author), Mandy Hemphill (Author), Karan Somaiya (Author), Laura H Hendrix (Author), Andrea A Gibson (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trialResearch in context
by: Lei Tian, et al.
Published: (2024) -
Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray
by: Xiaofei Wu, et al.
Published: (2022) -
Spray Freeze Dried Lyospheres<sup>®</sup> for Nasal Administration of Insulin
by: Tuğrul Mert Serim, et al.
Published: (2021) -
A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management
by: Peter H. Howarth
Published: (1995) -
Nano-Spray-Dried Levocetirizine Dihydrochloride with Mucoadhesive Carriers and Cyclodextrins for Nasal Administration
by: Mirella Mirankó, et al.
Published: (2023)